Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?

NCT01702805 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01702805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01702805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Lead sponsor
NICHD Neonatal Research Network
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2012
Completion date
April 29, 2025
Enrollment
1,824 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, bronchopulmonary dysplasia (bpd), infant, extremely low birth weight, infant, newborn, diseases, infant, small for gestational age